A 43-year-old man with pulmonary tuberculosis was started on standard anti-TB therapy. As expected, his uric acid level increased — a well-known effect of pyrazinamide. Although he had no history of gout or uric acid nephropathy, allopurinol was started to “prevent” complications
Fosfomycin’s IV formulation is now being used more widely, particularly in critically ill patients with MDR or DTR-GNB infections
🆕⚡⚡🟢Excellent comprehensive review
Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections
🔻Mechanism of action. Fosfomycin
🔻Antimicrobial Spectrum
🔻Resistance
🔻PK/PD Characteristics
🔻Dosing
🔻TDM
🔻Clinical Trials and Real-World Data
🔻Adverse Events
🔻ESCMID guidelines for the treatment of MDR GNB/fosfomycin
🔻Purposing Fosfomycin in the Treatment of DTR Gram-Negative Infections in Critically Ill Patients #IDXposts
https://t.co/tR3SDPoQ7n
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures
✅ Just Accepted
✍️ @UCSFDHM
🔗 https://t.co/gLeQ6ti8N0
Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomised controlled trials
✅ Just Accepted
🔗 https://t.co/cFXm1o4YyK
📢 Excited to share the publication of our landmark study on the Gam-COVID-Vac vaccine conducted in the UAE!
Proud to have led this work in collaboration with UAE University’s College of Medicine and Health Sciences.
https://t.co/sB8RGA4Xcj
Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis
✅ Just Accepted
🔗 https://t.co/CfGMwpvbVS
Thrilled to have this episode discussion with Dr. Shoham on transplant infectious diseases in the UAE, commercial transplantation, and donor evaluation challenges. Grateful for the opportunity to share perspectives. #TransplantID#UAE
https://t.co/6xgBasVAGO
📢 New Publication Alert
Despite the proven efficacy of HIV PrEP, its uptake across the GCC remains far below potential barriers.
In our latest expert review, we outline a strategic roadmap to advance PrEP adoption in the region.
https://t.co/tKaVhzQZoI
Successful participation this year at the largest European Infectious Disease Conference ESCMID - European Society of Clinical Microbiology and Infectious Diseases in Vienna
Two posters presented which describe genomic analysis of 2 unique cases
How safe and effective are MMR and VZV 💉after SOT in children? Pretty safe and pretty effective!
Need details? This 🔥table has it all in one place! The authors also propose inactivated vaccines >2 weeks pre-SOT and live vaccines >4 weeks
https://t.co/2uAa2vlAuo
Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial
✅ Just Accepted
🔗 https://t.co/yfmVOSeqOk
Publication Alert 🚨
This study aims to evaluate PrEP's value and effectiveness and to develop targeted recommendations for overcoming barriers and expanding PrEP programs to better serve the region's specific needs and populations at risk.
https://t.co/InqaSDfTwC
Publication Alert 🚨
Unusual instance of heart involvement. A 28-year-old man from India presented with a persistent cough and hemoptysis. Imaging revealed bilateral lung lesions along with cystic lesions in his right ventricle.
https://t.co/IP6SkU4r5h
We’re proud to announce the new EIDS board! With diverse expertise, they’ll lead us into an exciting new chapter ahead.
We also extend heartfelt gratitude to our outgoing members for their invaluable contributions.
Here's to growth and innovation ahead! #EIDS#Leadership
Thrilled to share that our editorial paper on “Organ vigilance in the Middle East: Challenges and prospects” was published today in @TheTxIDjournal
https://t.co/n8AiSua0F9
@AlmaghrabiReem@eids_uae@ema_abudhabi